AllI · Sterile fill-finish capacityII · Stoppers, syringes & drug-contact componentsIII · Pharmaceutical glass & vialsIV · Bioprocessing consumables & resinsV · API & small-molecule reshoringVI · CDMO capacity & the China exodusVII · Peptide & oligonucleotide manufacturingVIII · Sterile injectables & shortage economicsIX · Analytical instruments & QC releaseX · Private giants & exposure vehicles
| Ticker | Name | Tier ↓ | Quote | Mkt cap | 6M | Chokepoints |
|---|---|---|---|---|---|---|
| LZAGY | Lonza Group AG (unsponsored ADR) | core | $76.54-0.2% | $41.9B | +24.2% | fill-finish · api-reshoring · cdmo-capacity · peptides-oligos · private-giants |
| TMO | Thermo Fisher Scientific Inc. | core | $673.82-0.4% | $180.0B | +43.5% | fill-finish · bioprocessing · api-reshoring · cdmo-capacity · instruments-qc |
| CRL | Charles River Laboratories International, Inc. | watch | $345.37+1.7% | $8.9B | +103.4% | cdmo-capacity · instruments-qc |
| FUJIY | FUJIFILM Holdings Corporation (ADR) | watch | $10.76-0.2% | $26.7B | +19.2% | fill-finish · cdmo-capacity |
| SAMSUNGBIOLOGICS | Samsung Biologics Co., Ltd. | watch | private | — | via — | cdmo-capacity |
| WXIBF | WuXi Biologics (Cayman) Inc. | watch | $6.32+18.4% | $15.9B | +34.5% | cdmo-capacity |
| WUXAY | WuXi AppTec Co., Ltd. | speculative | $23.71-0.8% | $42.0B | +53.0% | api-reshoring · cdmo-capacity |
Quote shows the latest price and daily change; the 6M column is the total return over that window. Quotes delayed up to 15 minutes; tiers are editorial conviction, not ratings. Click a column header to sort.